期刊文献+

泮托拉唑钠冻干粉针剂生产工艺考察 被引量:2

Study on Improved Preparation Technique of Pantoprazole Sodium Freeze-dried Powder Injections
暂未订购
导出
摘要 目的:探讨泮托拉唑钠冻干粉针剂的生产工艺研究。方法:通过调节pH及加入适当比例的依地酸二钠(EDTA-2Na)使泮托拉唑钠冻干粉针达到良好的物理性质。结果:加入0.2%EDTA-2Na及配制好的泮托拉唑钠药液pH调到10.8~11,制成的粉针剂外观及溶液稳定性良好。结论:该方法较好地解决了泮托拉唑钠冻干粉针剂生产过程中出现的问题。 Objective: To explore the improved preparation methods of pantoprazole sodium freeze-dried powder injections. Method : Adjusting pH and adding appropriate proportion of EDTA-2Na were employed to improve the physical properties of pantoprazole so- dium freeze-dried powder injections. Result: When the pH was 10. 8-11 and the concentration of EDTA-2Na was 0. 2% , the freeze- dried powder showed better appearance and stability in solution. Conclusion: Both of the two methods can solve the problems in prepar- ing pantoprazole sodium freeze-dried powder injections.
作者 吴彩萍
出处 《中国药师》 CAS 2011年第11期1600-1601,共2页 China Pharmacist
关键词 泮托拉唑钠 冻干粉针剂 生产工艺 Pantoprazole Freeze-dried powder injections Preparation process
  • 相关文献

参考文献2

二级参考文献23

  • 1[1]Anonymous. Pantoprazole--a third pump inhibitor[J]. Drug Ther Bull, 1997,35(2):93-94.
  • 2[2]Sachs C. Proton pump inhibitors and acid-related disease[J]. Pharmaco Therapy, 1997,17(1):22-37.
  • 3[3]Bliesath H, Huber R, Hartmaun H, et al. Dose linearity of the phar-macokinetics of the new H+/K+-ATPase inhibitor pantoprazole after single intravenous administration [J]. J Clin Pharmacol Ther, 1996,34(Suppl 1):18-24.
  • 4[4]Huber R, Hartmaun M, Bliesath H, et al. Pharmacokinetics of panto-prazole in man[J]. J Clin Pharmacol Ther, 1996,34((Suppl 1): 7-16.
  • 5[5]Wurzer H, Sohutze K, Bethke T, et al . Efficacy and safety of panto-prazole in patients with gastroesophageal reflux disease using in intravenous-oral regim[J]. Hepatogastroent, 1999,46:1809-1815.
  • 6[6]Paul J, Metz D, Marton P, et al. Pharmacodynamic equivalence of oral and iv pantoprazole in GERD patients[J]. Am J Gastroenterol, 1998,93:1622, Abstract.
  • 7[7]Metz D C, Forsmark C E, Soffer E, et al. Zollinger-Ellison syndrome patients can replace oral proton pump inhibitors with intravenous pantoprazole without losing control of acid output[N]. Paper Presented at Digestive Disease Week. 1999-05-16(19).
  • 8[8]Koop H, Kuly Schepp W, Dammann H G. Comparative trial of panto-prazole and ranitidine in the treatment of reflux esophagitis results of a German multicenter study[J]. J Clin Gastroenterol, 1995,20(3):192-195.
  • 9[9]Bochenek W. Pantoprazole heals erosive esophagitis more effectively and provides greater symptomatic relief than placebo or nizatidine in gastro-esophageal reflux disease patients[N]. Paper Presented at Digestive Disease Week. 1999-05-16(19).
  • 10[10]Corinaldesi R, Valentini M, Belaiche J, et al. Pantoprazole and ome-prazole in the treatment of reflux esophagitis :a European multicentre study[J]. Aliment Pharmacol Ther, 1995,9:667-671.

共引文献362

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部